ARK Genomic Valuation
| ARKG Etf | USD 23.67 0.31 1.29% |
At this time, the entity appears to be overvalued. ARK Genomic Revolution shows a prevailing Real Value of $20.71 per share. The current price of the entity is $23.67. Our model approximates the value of ARK Genomic Revolution from reviewing the entity fundamentals such as Price To Earning of 41.86 X, price to sales of 7.63 X, and Number Of Employees of 330 as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, in the future, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that ARK Genomic's price fluctuation is not too volatile at this time. Calculation of the real value of ARK Genomic Revolution is based on 3 months time horizon. Increasing ARK Genomic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ARK Genomic Revolution is useful when determining the fair value of the ARK etf, which is usually determined by what a typical buyer is willing to pay for full or partial control of ARK Genomic. Since ARK Genomic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ARK Etf. However, ARK Genomic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.67 | Real 20.71 | Hype 23.55 | Naive 21.74 |
The real value of ARK Etf, also known as its intrinsic value, is the underlying worth of ARK Genomic Revolution ETF, which is reflected in its stock price. It is based on ARK Genomic's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ARK Genomic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ARK Genomic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ARK Genomic Revolution helps investors to forecast how ARK etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ARK Genomic more accurately as focusing exclusively on ARK Genomic's fundamentals will not take into account other important factors: ARK Genomic Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ARK Genomic's current stock value. Our valuation model uses many indicators to compare ARK Genomic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ARK Genomic competition to find correlations between indicators driving ARK Genomic's intrinsic value. More Info.ARK Genomic Revolution is the top ETF in price to earning as compared to similar ETFs. It is the top ETF in price to book as compared to similar ETFs fabricating about 0.08 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for ARK Genomic Revolution is roughly 12.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ARK Genomic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ARK Genomic's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ARK Genomic's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ARK Genomic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ARK Genomic and how it compares across the competition.
About ARK Genomic Valuation
The etf valuation mechanism determines the current worth of ARK Genomic Revolution on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ARK Genomic Revolution. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of ARK Genomic Revolution based exclusively on its fundamental and basic technical indicators. By analyzing ARK Genomic's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ARK Genomic's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ARK Genomic. We calculate exposure to ARK Genomic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ARK Genomic's related companies.The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States.
8 Steps to conduct ARK Genomic's Valuation Analysis
ETF's valuation is the process of determining the worth of any etf in monetary terms. It estimates ARK Genomic's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of etf valuation is a single number representing a ETF's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ARK Genomic's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ARK Genomic's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ARK Genomic's revenue streams: Identify ARK Genomic's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ARK Genomic's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ARK Genomic's growth potential: Evaluate ARK Genomic's management, business model, and growth potential.
- Determine ARK Genomic's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the ETF's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ARK Genomic's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.